[ad_1]
The opinions expressed by Entrepreneur contributors are their own.
You are reading Entrepreneur India, an international franchise of Entrepreneur Media.
For a long time, pharmaceutical marketing was all about physical contact for pharmaceutical brands with their target audience: doctors. However, this process was fraught with many inefficiencies, both in terms of time spent and money. But Dossely turned the tide.
Digital platforms specifically for healthcare professionals (HCPs), such as medical education sites, networking sites, medical associations, and medical journals, are increasingly available to help HCPs develop their expertise and connect with peer groups. Access. Through our programmatic tools, backed by our partnerships with specialized ad exchanges, we can present targeted pharmaceutical messaging to his HCPs based on their searches and needs on trending sites. These tools reduce inefficiencies by ensuring that ads are only seen by doctors in specific specialties.
With the help of its proprietary AI engine Espyian, Doceree has already targeted more than 1 million physicians across the United States. In India, the number is nearly 300,000.
The startup has been profitable across markets, growing more than 100% over the past year and increasing monthly revenue 5x from its Series A funding in April 2022 to date.
The company recently raised $35 million in Series B and aims to expand significantly around the world over the next two years.
Technical specifications
•Starting year: 2019
•no.Number of employees: 100 or more
•External funding received to date: $48 million
•Key Clients: We work with top 10 pharmaceutical brands in the world.
•Developed/Patented Intellectual Property: ESPIYAN
[ad_2]
Source link
